Eduardo Vilar-Gomez (Eduardo Vilar Gomez)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 24

Top Topics

Physical Activity

Top Venues

Hepatology (Baltimore, Md.)

Hepatology communications

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Gaurnizo-Ortiz, Lauren D Nephew, Eduardo Vilar-Gomez, Carla D Kettler, James E Slaven, Marwan S Ghabril, Archita P Desai, Eric S Orman, Naga Chalasani, Samer Gawrieh, Kavish R Patidar
Clinical characteristics and prognosis of hospitalized patients with moderate alcohol-associated hepatitis. Liver international : official journal of the International Association for the Study of the Liver (2023)
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Kavish R Patidar, Maria Guarnizo Ortiz, James E Slaven Ii, Lauren D Nephew, Eduardo Vilar-Gomez, Carla D Kettler, Marwan S Ghabril, Archita P Desai, Eric S Orman, Naga Chalasani, Samer Gawrieh
Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis. Hepatology communications 7 (12) (2023)
Eduardo Vilar-Gomez, Raj K Vuppalanchi, Samer Gawrieh, Niharika R Samala, Naga P Chalasani
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology (Baltimore, Md.) 77 (4) (2023)
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Maria Guarnizo-Ortiz, Eduardo Vilar-Gomez
Editorial: first-degree relatives of Mexican Americans with HCC are at increased risk of significant fibrosis. Alimentary pharmacology & therapeutics 57 (9) (2023)
Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew James Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J Hickman, Matthew Robert Kappus, Shelley Elizabeth Keating, Christopher J A Pugh, Yaron Rotman, Tracey G Simon, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Kathryn H Schmitz
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology communications 7 (4) (2023)
Eduardo Vilar-Gomez
Editorial: food insecurity, diet quality, racial and ethnic disparities in non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 56 (11-12) (2022)
Terry Cheuk Fung Yip, Eduardo Vilar-Gomez, Salvatore Petta, Yusuf Yilmaz, Grace Lai-Hung Wong, Leon A Adams, Victor de Lédinghen, Silvia Sookoian, Vincent Wai-Sun Wong
Geographical similarity and differences in the burden and genetic predisposition of NAFLD. Hepatology (Baltimore, Md.) (2022)
Eduardo Vilar-Gomez, Carlos Jose Pirola, Silvia Sookoian, Laura A Wilson, Tiebing Liang, Naga P Chalasani
PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features. Hepatology (Baltimore, Md.) 76 (5) (2022)
Samer Gawrieh, Laura A Wilson, Katherine P Yates, Oscar W Cummings, Eduardo Vilar-Gomez, Veeral H Ajmera, Kris V Kowdley, William M Rosenberg, James Tonascia, Naga P Chalasani
Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial. Hepatology communications 5 (5) (2021)
Luis C Bertot, Eduardo Vilar-Gomez, Jacob George, Leon A Adams
REPLY. Hepatology (Baltimore, Md.) 74 (1) (2021)
Eduardo Vilar-Gomez, Lauren D Nephew, Raj K Vuppalanchi, Samer Gawrieh, Andrea Mladenovic, Francis Pike, Niharika Samala, Naga P Chalasani
High quality diet, physical activity and college education are associated with low risk of NAFLD among the U.S. population. Hepatology (Baltimore, Md.) (2021)
Luis C Bertot, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, Manuel Romero, Rocio Aller-de la Fuente, Grace Lai-Hung Wong, Marlen Ivón Castellanos-Fernández, Mohammed Eslam, Archita P Desai, Gary P Jeffrey, Jacob George, Naga P Chalasani, Leon A Adams
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis. Hepatology (Baltimore, Md.) 73 (6) (2021)
Eduardo Vilar-Gomez, Naga Chalasani
Reply. Hepatology (Baltimore, Md.) 70 (2) (2020)
Eduardo Vilar-Gomez, Naga Chalasani
Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply. Alimentary pharmacology & therapeutics 50 (7) (2020)
Eduardo Vilar-Gomez, Naga Chalasani
Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. Authors' reply. Alimentary pharmacology & therapeutics 50 (7) (2020)
Eduardo Vilar-Gomez, Raj Vuppalanchi, Samer Gawrieh, Marwan Ghabril, Romil Saxena, Oscar W Cummings, Naga Chalasani
Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis. Hepatology (Baltimore, Md.) 71 (2) (2019)
Eduardo Vilar-Gomez, Raj Vuppalanchi, Archita P Desai, Samer Gawrieh, Marwan S Ghabril, Romil Saxena, Oscar W Cummings, Naga Chalasani
Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis. Alimentary pharmacology & therapeutics 50 (3) (2019)
Lara Dakhoul, Samer Gawrieh, Keaton R Jones, Marwan Ghabril, Chelsey McShane, Eric Orman, Eduardo Vilar-Gomez, Naga Chalasani, Lauren Nephew
Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden. Hepatology communications 3 (1) (2018)
Eduardo Vilar-Gomez, Luis Calzadilla-Bertot, Scott L Friedman, Bienvenido Gra-Oramas, Licet Gonzalez-Fabian, Sacha Lazo-Del Vallin, Moises Diago, Leon A Adams
Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH. Liver international : official journal of the International Association for the Study of the Liver 37 (12) (2017)